Sisram Medical to Report FY2023 Financial Results on March 20 and Hold a Conference Call on March 21
Sisram Medical to Report FY2023 Financial Results on March 20 and Hold a Conference Call on March 21
Sisram FY2023 earnings conference call to be held on March 21, at 8:00 a.m. Eastern Time
Sisram FY2023 業績電話會議將於美國東部時間 3 月 21 日上午 8:00 舉行
HONG KONG, March 14, 2024 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused branding, including Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care, and more, today announced that it expects to release its annual results for FY2023, ended December 31, on Wednesday, March 20, 2024.
香港，2024 年 3 月 14 日 /PRNewswire/ — Sisram Medical Ltd（”公司“或”西斯拉姆“，1696.HK；連同其子公司統稱爲”小組“）是一家全球消費者健康集團，擁有由業務構件和以消費者爲中心的品牌組成的卓越協同生態系統，包括能量設備、注射劑、美容和數字牙科、個人護理等，今天宣佈，預計將於2024年3月20日星期三發佈截至12月31日的 FY2023 年度業績。
Sisram's management team will host a conference call to discuss the financial results on Thursday, March 21, 2024, at 8:00 a.m. Eastern Time.
Sisram的管理團隊將於美國東部時間2024年3月21日星期四上午8點舉行電話會議，討論財務業績。
Speakers will include: Mr. Liu Yi, Sisram's Chairman, Mr. Lior Dayan, Sisram's Chief Executive Officer, Mr. Doron Yannai, Alma's CFO, and Ms. Qianli Fang, Sisram's VP of IR and Secretary of the Board. Following the prepared remarks, management will be available for a question-and-answer session.
演講嘉賓將包括：Sisram董事長劉毅先生、Sisram首席執行官Lior Dayan先生、Alma首席財務官Doron Yannai先生以及Sisram投資者關係副總裁兼董事會秘書方千里女士。在準備好的發言之後，管理層將參加問答環節。
Please register in advance for the webinar using the link below:
請使用以下鏈接提前註冊網絡研討會：
After registering, you will receive a confirmation email with instructions for joining the webinar.
註冊後，您將收到一封確認電子郵件，其中包含參加網絡研討會的說明。
The conference call will begin at:
8:00 a.m. Eastern Time
5:00 a.m. Pacific Time
3:00 p.m. Israel Time
電話會議將從以下時間開始：
美國東部時間上午 8:00
太平洋時間凌晨 5:00
以色列時間下午 3:00
A replay will also be available on Sisram Medical's IR Events & Presentations page.
重播內容也將在Sisram Medical的紅外活動和演示頁面上播出。
About Sisram Medical Ltd
關於西斯拉姆醫療有限公司
Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, ranging from Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care and more. The company is majority-owned by Fosun Pharma, one of China's leading healthcare groups. Sisram Medical went public on the Main Board of the Hong Kong Exchange in September 2017.
Sisram Medical Ltd（1696.HK）是一家全球消費者健康集團，擁有首個由業務構件和以消費者爲中心的品牌組成的協同生態系統，涵蓋能源設備、注射劑、美容和數字牙科、個人護理等。該公司由中國領先的醫療集團之一復星醫藥持有多數股權。Sisram Medical於2017年9月在香港交易所主板上市。
Sisram Medical – Enhancing Quality of Life
Sisram Medical — 提高生活質量